Keywords: shire, income, hits, 278m, sales, up, uk-based
Shire's 2006 income hits $278M, sales up 16%
Article | 26 February 2007
UK-based pharmaceutical company Shire says that, for the full year 2006, its net income on a US generally-accepted accounting principals basis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
